Effect of DASH on HF Outcomes Heart Failure Status in Older Adults (DASH HF)
Effect of Dietary Approaches to Stop Hypertension Diet on Heart Failure Status in Older Adults
1 other identifier
interventional
38
1 country
1
Brief Summary
The purpose of this study is to examine the effect of the Dietary Approaches to Stop Hypertension (DASH) diet has on heart failure status in older adults. This study is important because it may provide a low-cost strategy to help reduce hospitalizations and deaths for heart failure patients. Participants will be adults age 65 and older with heart failure. They will have 4 study visits, each lasting about 2 hours, and will be in the study for 12 weeks. They will also be asked about their dietary consumption 6 times, each time lasting about 45 minutes. All in-person study visits will take place in the Emory GCRC. Participants will have physical exams, body measurements, blood tests, urinalysis, chart review, and answer surveys. They will be randomized to eat only the DASH diet provided to them for 4 weeks either at the beginning or end of their participation in the study. Participants will be recruited from heart failure patients at Emory University Hospital, Emory University Hospital Midtown, and Emory Outpatient Advanced Heart Failure Therapy Center. The total enrollment planned under Emory's oversight, accounting for screen failures and withdrawals, will be n=38 participants. The study team will obtain informed consent prior to the first study visit either in person, or, alternatively, over the phone, if requested by participants. Specimens and data obtained in this study will not be banked for future use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Mar 2024
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedMarch 6, 2024
February 1, 2024
1.2 years
February 28, 2024
February 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
B-natriuretic peptide (BNP)
Clinically relevant natriuretic peptide
Study visit 1-4
Secondary Outcomes (2)
N-terminal-proBNP (NT-proBNP)
Study visit 1-4
Systolic and Diastolic Pulmonary Artery Pressures
Patient-driven measurement data points during intervention/control phase (8 weeks)
Study Arms (2)
Dietary Approaches to Stop Hypertension Diet
EXPERIMENTALUsual Diet
NO INTERVENTIONInterventions
The DASH diet is a heart-healthy eating pattern that is focused on adequate consumption of fruits, vegetables, whole grains, low-fat dairy, fish, poultry, beans, nuts, and vegetables oils while emphasizing limited intake of foods containing saturated fat, such as fatty red meats, full-fat dairy products, and tropical oils, such as coconut, palm kernel, and palm oils, as well as sugar-sweetened beverages and sweets. The chosen 4 week intervention duration phase is consistent with previous research showing positive effects of consuming a sodium-reduced dietary intervention on volume status and is longer than in other studies showing positive effects of DASH diet consumption on cardiac outcomes among HF patients. Potential carryover effects are minimized by a washout period of 4 weeks. The meal plan has been previously developed based on NHLBI guidelines for the DASH diet.
Eligibility Criteria
You may qualify if:
- + years of age
- Heart failure diagnosis and symptoms, as outlined by the 2021 European Society of Cardiology diagnostic guidelines
- Residence within 50 miles of Emory University
- Have undergone hemodynamic monitoring device implantation (CardioMEMS, Abbott)
- Have received optimized HF therapy for 3+ months post CardioMEMS implantation
You may not qualify if:
- Heart failure-related hospitalization or heart failure medication changes within 1 month
- Renal disease stages IV-V
- Expected survival \< 12 months
- Dementia or Alzheimer's disease
- Limited English literacy and communication skills
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Georgialead
- Emory Universitycollaborator
Study Sites (1)
Emory Clinical Cardiovascular Research Center (ECCRI)
Atlanta, Georgia, 30322, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 28, 2024
First Posted
March 6, 2024
Study Start
March 1, 2024
Primary Completion
May 1, 2025
Study Completion
June 1, 2025
Last Updated
March 6, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share